Annotated Medicine and Device Lists
| List | Section | Observation |
|---|---|---|
| Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 | 03.03. FARMACOS ANTIPARASITARIOS | No observations |
| List | Section | Observation |
|---|---|---|
| Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. | Anti-Infectives Antimalarials | No observations |
| Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. | CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. |
Others observations: X 8 TABLETAS. |
| Paraguay. Lista de Medicamentos Esenciales. 2009 | 01. ANTIPROTOZOARIOS | No observations |
| Guyana. Essential Medicines List. 2020-2021 | Reserve second-line medicines used to treat Malaria | No observations |
| Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 | 8:20 Antimalarial agents | No observations |
| Haiti. National List of Essential Medicines | 06.05.03.02 For prophylaxis |
Others observations: For use in pregnancy instead of doxycycline |
| Barbados. Barbados National Drug Formulary (BNDF) | 08.30 Antiprotozoals | No observations |
| Bahamas. Drug Formulary | 07.04.01 Antimalarials | No observations |
| Cayman Islands Health Services Authority Pharmacy Drug Formulary | 05.04.01 Antimalarial Drugs | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 6.5.3.2 For chemoprevention |
Age or weight restriction:
>5 kg or >3 months. Others observations: >5 kg or >3 months. |
| WHO Model List of Essential Medicines (2021) | 6.5.3.1. For curative treatment |
Others observations: To be used in combination with artesunate 50 mg. |
| PAHO Strategic Fund Medicine List | 2.7.2. Anti-malarial | No observations |
| Peru | 6.5.3 Antimalarials | No observations |
| Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 07.06 ANTI-MALARIALS | No observations |
| Suriname. NGK-C-011 | 6.10 Anti-Protozoan Agents: Anti-Malaria Agents | No observations |